Navigation Links
Alzheimer's - From Curiosity To Worldwide Disease

On Nov 3, 1906 the psychiatrist Alois Alzheimer presented a paper entitled "Regarding a curious disease of the cortex".//

Alzheimer's colleagues did not immediately recognise the importance of his discovery. One century later, the name of Alois Alzheimer (1864-1915) is known across the globe.

In Germany alone, a country of 82 million people, between 700,000 to one million patients suffer from the brain disease named after the scientist. Worldwide over 20 million are said to have the disease.

A four-day conference starting in Tuebingen on Nov 2 intends to illuminate history and future of Alzheimer's research.

"When Alzheimer first announced his discovery, he only saw the final stage and had no idea about the dynamics of the illness. This has only been discovered afterwards," the host of the Alzheimer conference, Mathias Jucker says.

To date, no cure has been found for the disease.

"Even if we could find a way to stop Alzheimer from developing, and it would no longer pose a problem for society, the ageing brain remains a risk factor for a range of diseases," says the neurobiologist, who works at the Hertie Institute for Clinical Brain Research in Tuebingen.

"Not everyone gets Alzheimer, and it is not a normal consequence of ageing," Jucker insists in view of an increase of cases.

Alois Alzheimer's first patient, Auguste Deter, was only 51 years old when she was brought to the Frankfurt Institution for Lunatics and Epileptics.

The woman said she had "lost herself". Alzheimer was puzzled by her memory loss. Up to this point the patient had been healthy, did not have a history of psychological troubles and had not experienced anything traumatic.

Alzheimer meticulously documented Auguste's memory loss on 31 handwritten pages. His notes include conversations held with "Auguste D".

"What is your name?" "Auguste." - "Surname?" "Auguste". "What is your h usband's name?" "Auguste, I believe."

After the patient's death on April 8, 1906 at "1/4 to 6 in the morning", Alzheimer had Auguste Deter's brain sent to his lab. He discovered massive neuronal malfunction and deposits.

Half a year later, the physician from Tuebingen held a presentation at the congregation of southwest German alienists, where he declared, "My case Auguste D. is deviant from all known disease patterns."

Since, scientist understood that the disease is caused by a gradual degeneration of the neurones and usually sets on after the age of 65.

Many patients no longer recognise family members and friends, have orientation problems and struggle with speech.

"The presentation in Tuebingen did not necessarily get the hoped for attention," writes Alzheimer biographer Konrad Maurer.

Hundred years later, the situation has reversed. In view of an ageing society, Alzheimer's disease is regarded as the "widespread disease of the future".

The German Alzheimer Association expects that the number of Alzheimer patients in Germany will exceed two million by the year 2040.

Thomas Kunczik, manager of "Hirnliga", a German association of Alzheimer's researchers, hopes that the anniversary will boost prevention and therapy of brain diseases.

But Kunciyik is sceptical. "Alzheimer is still a frightening disease that many people prefer not to think about."

Source-IANS
'"/>




Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Decrease in testosterone levels lead to Alzheimers
3. Smokers are prone to Alzheimers
4. Over-The-Counter Drugs May Prevent Alzheimers
5. Alzheimers followed by head injury
6. Vitamin E useful for Alzheimers
7. Staying mentally energitic prevents Alzheimers
8. Researchers trick Alzheimers Enzyme
9. Drug Offers Hope for Alzheimers disease
10. Alzheimers with psychosis runs in families
11. Blood test may aid foretell Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: